오클라호마의 자궁내막암 임상 시험
자궁내막암 관련 연구 29개가 오클라호마 내 여러 지역에서 참여자를 모집하고 있습니다.
오클라호마의 도시
공식 연구 텍스트(영어)
Study of AVZO-021 in Patients With Advanced Solid Tumors
- Avenzo Therapeutics Recruiting Site, Oklahoma City
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT05867251Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
- University of Oklahoma Health Sciences Center, Oklahoma City
- Mercy Hospital Oklahoma City, Oklahoma City
- Oklahoma Cancer Specialists and Research Institute-Tulsa, Tulsa
피험자 모집 중3상
18세 이상 · 여성 · 2026. 9. 28. 업데이트됨 · NCT05256225Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
- University of Oklahoma Health Sciences Center, Oklahoma City
피험자 모집 중2상
18세 이상 · 여성 · 2026. 9. 28. 업데이트됨 · NCT05112601Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- University of Oklahoma Health Sciences Center, Oklahoma City
피험자 모집 중2상
전 연령 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT05564377Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
- Stephenson Cancer Center, Oklahoma City
피험자 모집 중1/2상
18세 이상 · 여성 · 2026. 9. 25. 업데이트됨 · NCT03564340Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
- University of Oklahoma Health Sciences Center, Oklahoma City
피험자 모집 중3상
18세 이상 · 여성 · 2026. 9. 25. 업데이트됨 · NCT07198074Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
- University of Oklahoma Health Sciences Center, Oklahoma City
피험자 모집 중2상
18세 이상 · 여성 · 2026. 9. 24. 업데이트됨 · NCT05640999Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- University of Oklahoma, Oklahoma City
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT06128551A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
- Peggy & Charles Stephenson Oklahoma Cancer Center, Oklahoma City
피험자 모집 중3상
18세 이상 · 여성 · 2026. 9. 17. 업데이트됨 · NCT06340568A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
- Oklahoma Cancer Specialists and Research Institute, LLC ( Site 6047), Tulsa
피험자 모집 중3상
18세 이상 · 여성 · 2026. 9. 17. 업데이트됨 · NCT06952504The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- University of Oklahoma, Oklahoma City
피험자 모집 중1/2상
12세 이상 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT04585750Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer
- University of Oklahoma Health Sciences Center, Oklahoma City
피험자 모집 중1상
18세 이상 · 여성 · 2026. 9. 3. 업데이트됨 · NCT05950464DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Research Site, Oklahoma City
피험자 모집 중3상
18세 이상 · 여성 · 2026. 9. 3. 업데이트됨 · NCT06989112Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
- OU Health Stephenson Cancer Center, Oklahoma City
피험자 모집 중1상
15세 이상 · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT06276491A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
- Stephenson Cancer Center at OU Health, Oklahoma City
피험자 모집 중2상
18세 이상 · 여성 · 2026. 8. 21. 업데이트됨 · NCT05548296A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
- Normunity Investigational Site, Oklahoma City
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 18. 업데이트됨 · NCT07182149A Study of DM002 in Patients With Advanced Solid Tumors
- University of Oklahoma Health Sciences Center, Oklahoma City
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 7. 업데이트됨 · NCT06751329Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- University of Oklahoma - Health Sciences Center, Oklahoma City
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 4. 업데이트됨 · NCT05579366A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Stephenson Cancer Center, Oklahoma City
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 7. 30. 업데이트됨 · NCT04657068Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
- Mercy Hospital - OKC, Oklahoma City
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 6. 29. 업데이트됨 · NCT07327489A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
- Stephenson Cancer Center Oklahoma University Health, Oklahoma City
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 6. 29. 업데이트됨 · NCT05377996A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
- University of Oklahoma Health Stephenson Cancer Center, Oklahoma City
피험자 모집 중1/2상
18세 이상 · 여성 · 2026. 4. 1. 업데이트됨 · NCT04486352Uterine Preservation Via Lifestyle Transformation
- University of Oklahoma, Oklahoma City
피험자 모집 중2상
18세 이상 · 여성 · 2026. 1. 20. 업데이트됨 · NCT05903131A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
- Dren Investigational Site, Oklahoma City
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 1. 7. 업데이트됨 · NCT06999187Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer
- University of Oklahoma, Oklahoma City
피험자 모집 중1상
18세 이상 · 여성 · 2025. 12. 11. 업데이트됨 · NCT06795009Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer
- Oklahoma University Stephenson Cancer Center, Oklahoma City
피험자 모집 중2상
18세 이상 · 모든 성별 · 2025. 11. 13. 업데이트됨 · NCT05997017A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.
- University of Oklahoma, Oklahoma City
피험자 모집 중2상
18세 ~ 70세 · 여성 · 2025. 10. 30. 업데이트됨 · NCT06481592SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Tulsa
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2025. 10. 28. 업데이트됨 · NCT03452774Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
- Oklahoma Cancer Specialists and Research Institute, Tulsa
피험자 모집 중2/3상
18세 이상 · 여성 · 2024. 5. 2. 업데이트됨 · NCT05797831ClinicalTrials.gov 출처, 2026. 9. 29. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.